Literature DB >> 21756913

β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways.

Giovanni Fajardo1, Mingming Zhao, Gerald Berry, Lee-Jun Wong, Daria Mochly-Rosen, Daniel Bernstein.   

Abstract

β-adrenergic receptors (β-ARs) modulate cardiotoxicity/cardioprotection through crosstalk with multiple signaling pathways. We have previously shown that β2-ARs are cardioprotective during exposure to oxidative stress induced by doxorubicin (DOX). DOX cardiotoxicity is mediated in part through a Ca(2+)-dependent opening of the mitochondrial permeability transition (MPT), however the signals linking a cell surface receptor like the β2-AR to regulators of mitochondrial function are not clear. The objective of this study was to assess mechanisms of crosstalk between β2-ARs and mitochondrial cell death pathways. DOX administered to WT mice resulted in no acute mortality, however 85% of β2-/- mice died within 30 min. Several pro- and anti-survival pathways were altered. The pro-survival kinase, εPKC, was decreased by 64% in β2-/- after DOX vs WT (p<0.01); the εPKC activator ψεRACK partially rescued these mice (47% reduction in mortality). Activity of the pro-survival kinase Akt decreased by 76% in β2-/- after DOX vs WT (p<0.01). The α1-antagonist prazosin restored Akt activity to normal and also partially reversed the mortality (45%). Deletion of the β2-AR increased rate of Ca(2+) release by 75% and peak [Ca(2+)](i) by 20% respectively in isolated cardiomyocytes; the Ca(2+) channel blocker verapamil also partially rescued the β2-/- (26%). Mitochondrial architecture was disrupted and complex I and II activities decreased by 40.9% and 34.6% respectively after DOX only in β2-/-. The MPT blocker cyclosporine reduced DOX mortality by 41% and prazosin plus cyclosporine acted synergistically to decrease mortality by 85%. β2-ARs activate pro-survival kinases and attenuate mitochondrial dysfunction during oxidative stress; absence of β2-ARs enhances cardiotoxicity via negative regulation of survival kinases and enhancement of intracellular Ca(2+), thus predisposing the mitochondria to opening of the MPT.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21756913      PMCID: PMC3184305          DOI: 10.1016/j.yjmcc.2011.06.019

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  54 in total

1.  Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats.

Authors:  S M Yu; S Y Hsu; F N Ko; C C Chen; Y L Huang; T F Huang; C M Teng
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

Review 2.  Heart mitochondria: gates of life and death.

Authors:  Asa B Gustafsson; Roberta A Gottlieb
Journal:  Cardiovasc Res       Date:  2007-08-21       Impact factor: 10.787

3.  Heart levels of adriamycin in normal and tumor-bearing mice.

Authors:  M G Donelli; A Martini; T Colombo; A Bossi; S Garattini
Journal:  Eur J Cancer       Date:  1976-11       Impact factor: 9.162

4.  Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.

Authors:  Ismayil Ahmet; Melissa Krawczyk; Weizhong Zhu; Anthony Yiu-Ho Woo; Christopher Morrell; Suresh Poosala; Riu-Ping Xiao; Edward G Lakatta; Mark I Talan
Journal:  J Pharmacol Exp Ther       Date:  2008-02-20       Impact factor: 4.030

5.  Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.

Authors:  Partha Mukhopadhyay; Mohanraj Rajesh; Sándor Bátkai; Yoshihiro Kashiwaya; György Haskó; Lucas Liaudet; Csaba Szabó; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

6.  Inhibition of cytochrome c release by 10-N-nonyl acridine orange, a cardiolipin-specific dye, during myocardial ischemia-reperfusion in the rat.

Authors:  Guo-Xing Zhang; Shoji Kimura; Koji Murao; Koji Obata; Hiroko Matsuyoshi; Miyako Takaki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-25       Impact factor: 4.733

Review 7.  Calcium, ATP, and ROS: a mitochondrial love-hate triangle.

Authors:  Paul S Brookes; Yisang Yoon; James L Robotham; M W Anders; Shey-Shing Sheu
Journal:  Am J Physiol Cell Physiol       Date:  2004-10       Impact factor: 4.249

8.  The mitochondrial 13513G>A mutation is associated with Leigh disease phenotypes independent of complex I deficiency in muscle.

Authors:  Ariel Brautbar; Jing Wang; Jose E Abdenur; Richard C Chang; Janet A Thomas; Theresa A Grebe; Cynthia Lim; Shao-Wen Weng; Brett H Graham; Lee-Jun Wong
Journal:  Mol Genet Metab       Date:  2008-05-20       Impact factor: 4.797

9.  Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model.

Authors:  K K Chan; J L Cohen; J F Gross; K J Himmelstein; J R Bateman; Y Tsu-Lee; A S Marlis
Journal:  Cancer Treat Rep       Date:  1978-08

10.  Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.

Authors:  Ping Xiang; Hai Yan Deng; Karen Li; Guo-Ying Huang; Yuan Chen; Liu Tu; Pak Cheung Ng; Nga Hin Pong; Hailu Zhao; Lei Zhang; Rita Yn Tz Sung
Journal:  Cancer Chemother Pharmacol       Date:  2008-04-01       Impact factor: 3.333

View more
  20 in total

1.  Sarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance, and opioidergic cardioprotection.

Authors:  Louise E See Hoe; Jan M Schilling; Emiri Tarbit; Can J Kiessling; Anna R Busija; Ingrid R Niesman; Eugene Du Toit; Kevin J Ashton; David M Roth; John P Headrick; Hemal H Patel; Jason N Peart
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-25       Impact factor: 4.733

Review 2.  Protective transcriptional mechanisms in cardiomyocytes and cardiac fibroblasts.

Authors:  Cameron S Brand; Janet K Lighthouse; Michael A Trembley
Journal:  J Mol Cell Cardiol       Date:  2019-04-28       Impact factor: 5.000

Review 3.  Therapeutic potential of Pnmt+ primer cells for neuro/myocardial regeneration.

Authors:  Aaron Owji; Namita Varudkar; Steven N Ebert
Journal:  Am J Stem Cells       Date:  2013-12-22

4.  Patient-Specific Pluripotent Stem Cells in Doxorubicin Cardiotoxicity: A New Window Into Personalized Medicine.

Authors:  Daniel Bernstein; Paul Burridge
Journal:  Prog Pediatr Cardiol       Date:  2014-12-01

Review 5.  Insulin and β Adrenergic Receptor Signaling: Crosstalk in Heart.

Authors:  Qin Fu; Qingtong Wang; Yang K Xiang
Journal:  Trends Endocrinol Metab       Date:  2017-02-28       Impact factor: 12.015

6.  β-Adrenergic signaling, monoamine oxidase A and antioxidant defence in the myocardium of SHR and SHR-mtBN conplastic rat strains: the effect of chronic hypoxia.

Authors:  Klara Hahnova; Iveta Brabcova; Jan Neckar; Romana Weissova; Anna Svatonova; Olga Novakova; Jitka Zurmanova; Martin Kalous; Jan Silhavy; Michal Pravenec; Frantisek Kolar; Jiri Novotny
Journal:  J Physiol Sci       Date:  2017-05-31       Impact factor: 2.781

7.  Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice.

Authors:  Giovanni Fajardo; Mingming Zhao; Takashi Urashima; Sara Farahani; Dong-Qing Hu; Sushma Reddy; Daniel Bernstein
Journal:  J Mol Cell Cardiol       Date:  2013-08-03       Impact factor: 5.000

8.  Anthracycline Cardiotoxicity: Worrisome Enough to Have You Quaking?

Authors:  Daniel Bernstein
Journal:  Circ Res       Date:  2018-01-19       Impact factor: 17.367

9.  Inhibition of the Mitochondrial Permeability Transition for Cytoprotection: Direct versus Indirect Mechanisms.

Authors:  Cécile Martel; Le Ha Huynh; Anne Garnier; Renée Ventura-Clapier; Catherine Brenner
Journal:  Biochem Res Int       Date:  2012-05-22

10.  RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy.

Authors:  Tarek Magdy; Zhengxin Jiang; Mariam Jouni; Hananeh Fonoudi; Davi Lyra-Leite; Gwanghyun Jung; Marisol Romero-Tejeda; Hui-Hsuan Kuo; K Ashley Fetterman; Mennat Gharib; Brian T Burmeister; Mingming Zhao; Yadav Sapkota; Colin J Ross; Bruce C Carleton; Daniel Bernstein; Paul W Burridge
Journal:  Cell Stem Cell       Date:  2021-09-15       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.